Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,200,939
in 8 filings

Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-01 Sethuraman Natarajan Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +66,800 66,800
2024-02-15 Doshi Dipal CEO Sale 10b5-1 −1,000 $15.00 $15K 243,279
2024-01-16 Doshi Dipal CEO Sale 10b5-1 −1,000 $15.99 $16K 244,279
2023-12-26 WENTWORTH KORY JAMES Chief Financial Officer Option exercise 10b5-1 +94 $2.10 $197 49,665
2023-12-26 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −94 $16.67 $2K 49,571
2023-12-26 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −94 52,157
2023-12-22 WENTWORTH KORY JAMES Chief Financial Officer Option exercise 10b5-1 +10,206 $2.10 $21K 59,777
2023-12-22 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −6,529 $15.24 $100K 53,248
2023-12-22 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −3,677 $16.48 $61K 49,571
2023-12-22 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −10,206 52,251
2023-12-21 WENTWORTH KORY JAMES Chief Financial Officer Option exercise 10b5-1 +2,200 $2.10 $5K 51,771
2023-12-21 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −2,200 $15.07 $33K 49,571
2023-12-21 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −2,200 62,457
2023-12-20 Doshi Dipal President and CEO Sale 10b5-1 −1,000 $15.00 $15K 245,279
2023-11-13 Doshi Dipal President and CEO Sale 10b5-1 −1,000 $16.23 $16K 246,279
2023-10-17 Doshi Dipal President and CEO Sale 10b5-1 −1,000 $15.00 $15K 247,279
2023-09-13 Doshi Dipal President and CEO Sale 10b5-1 −1,000 $15.00 $15K 248,279
2023-09-06 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −904 $13.45 $12K 49,617
2023-09-06 WENTWORTH KORY JAMES Chief Financial Officer Sale 10b5-1 −46 $14.03 $645 49,571
2023-09-06 KREHER NERISSA Chief Medical Officer Sale 10b5-1 −871 $13.46 $12K 40,058

Page 13 of 26 · 517 trades